Politics1 min read

STAT+: El-Sayed claps back at RFK Jr., and FDA’s ‘enforcement discretion’ on peptides

By · Via STAT Health · Published by Everything Blog

In short

Abdul El-Sayed, a Democratic candidate running for the U.S. Senate in Michigan, issued a response targeting statements made by Robert F. Kennedy Jr. El-Sayed brings a clinical and administrative perspective to the race as a federally funded health equity researcher and former local public health director. Alongside this campaign development, recent policy reporting examined the Food and Drug Administration's enforcement discretion practices regarding peptides. The accounts were detailed by STAT's D.C. Diagnosis, an outlet tracking the intersection of medicine and federal policy.

Key points

  • Michigan's Democratic Senate race features a candidate who openly advocates for single-pa…: Michigan's Democratic Senate race features a candidate who openly advocates for single-payer health care reform.
  • Robert F. Kennedy Jr. faces public opposition from trained public health experts running…: Robert F. Kennedy Jr. faces public opposition from trained public health experts running for national office.
  • Federal regulators are actively managing peptide policies through administrative enforcem…: Federal regulators are actively managing peptide policies through administrative enforcement discretion.

Sources checked by our analysis pipeline: 1

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Care to test your knowledge of which fellas Trump thinks are hot? Send news tips and hunks to [email protected] or John_Wilkerson.07 on Signal.

El-Sayed’s clapback

Abdul El-Sayed is the Democratic Senate candidate in Michigan. He’s also “a second-generation immigrant, a federally funded health equity researcher, a former local public health director, and an evangelist for single-payer health care,” according to Anil Oza’s profile.

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Politics